Chongqing Hongxiang Yixintang Pharmaceutical Co., Ltd. announced that it has received CNY 14 million in funding from Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd.
January 13, 2015 at 11:00 pm EST
Share
Chongqing Hongxiang Yixintang Pharmaceutical Co., Ltd. announced that it will receive CNY 14,000,000 in an equity round of funding from existing investor Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. on November 13, 2014. The investor will continue to hold 100% stake in the company upon completion of the transaction. The registered capital of the company will increase from CNY 20,000,000 to CNY 34,000,000 upon completion of the transaction. On the same date, the transaction was approved at the 5th extraordinary shareholders' meeting of 2014 of the investor.
On January 14, 2015, Chongqing Hongxiang Yixintang Pharmaceutical Co., Ltd. closed the transaction. The company obtained business license approved and issued by the Administration of Commerce and Industry and completed its change of business registration.
Yixintang Pharmaceutical Group Co., Ltd., formerly Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd., is a China-based company principally engaged in the pharmaceutical chain retailing and pharmaceutical wholesaling businesses. The Company's main products include traditional Chinese medicines, western medicines, medical equipment, birth control products and disinfection products, among others. The Company distributes its products through regular chain drugstores. The Company mainly operates its business in domestic market, with southwest area of China as its main market.
Chongqing Hongxiang Yixintang Pharmaceutical Co., Ltd. announced that it has received CNY 14 million in funding from Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd.